Extraintestinal focal infections in adults with Salmonella enterica serotype Choleraesuis bacteremia

Journal of Microbiology, Immunology and Infection

Volumn 40, Issue 3, 2007, Pages 240-247

  Chen, Po Lin ^a   Wu, Chi Jung ^a   Chang, Chia Ming ^a   Lee, Hsin Chun ^a,b   Lee, Nan Yao ^a   Shih, Hsin I ^a   Lee, Ching Chi ^a   Ko, Nai Ying ^a,b   Wang, Li Rong ^a   Ko, Wen Chien ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Bacteremia; Bacterial; Drug resistance; Microbial sensitivity tests; Mortality; Salmonella enterica

Indexed keywords

AMPICILLIN; AZTREONAM; CEFEPIME; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ERTAPENEM; IMIPENEM; LEVOFLOXACIN; MEROPENEM; NALIDIXIC ACID;

ADULT; AGE; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD CULTURE; CONFIDENCE INTERVAL; CRITICALLY ILL PATIENT; CULTURE MEDIUM; FEMALE; HIGH RISK POPULATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; MULTIVARIATE ANALYSIS; MYCOTIC ANEURYSM; NONHUMAN; OSTEOMYELITIS; RISK FACTOR; SALMONELLA ENTERICA CHOLERASUIS; SALMONELLOSIS; SHOCK; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; COMORBIDITY; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SALMONELLA ENTERICA; SALMONELLA INFECTIONS; TAIWAN;

EID: 34948858964     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Hohmann EL. Nontyphoidal salmonellosis. Clin Infect Dis. 2001;32:263-9.
2. Threlfall EJ, Hall ML, Rowe B. Salmonella bacteraemia in England and Wales, 1981-1990. J Clin Pathol. 1992;45:34-6.
3. Chen YH, Chen TP, Lu PL, Su YC, Hwang KP, Tsai JJ, et al. Salmonella choleraesuis bacteremia in southern Taiwan. Kaohsiung J Med Sci. 1999;15:202-8.
4. Chiu S, Chiu CH, Lin TY. Salmonella enterica serotype Choleraesuis infection in a medical center in northern Taiwan. J Microbiol Immunol Infect. 2004;37:99-102.
5. Chiu CH, Lin TY, Ou JT. Predictors for extraintestinal infection of non-typhoidal Salmonella in patients without AIDS. Int J Clin Pract. 1999;53:161-4.
6. Chiu CH, Lin TY, Ou JT. Prevalence of the virulence plasmids of nontyphoid Salmonella in the serovars isolated from humans and their association with bacteremia. Microbiol Immunol. 1999;43:899-903.
7. Galofre J, Moreno A, Mensa J, Miro JM, Gatell JM, Almela M, et al. Analysis of factors influencing the outcome and development of septic metastasis or relapse in Salmonella bacteremia. Clin Infect Dis. 1994;18:873-8.
8. Su LH, Chiu CH, Kuo AJ, Chia JH, Sun CF, Leu HS, et al. Secular trends in incidence and antimicrobial resistance among clinical isolates of Salmonella at a university hospital in Taiwan, 1983-1999. Epidemiol Infect. 2001;127:207-13.
9. Hsu RB, Tsay YG, Chen RJ, Chu SH. Risk factors for primary bacteremia and endovascular infection in patients without acquired immunodeficiency syndrome who have nontyphoid salmonellosis. Clin Infect Dis. 2003;36:829-34.
10. Ko WC, Yan JJ, Yu WL, Lee HC, Lee NY, Wang LR, et al. A new therapeutic challenge for old pathogens: community-acquired invasive infections caused by ceftriaxone- and ciprofloxacin-resistant Salmonella enterica serotype choleraesuis. Clin Infect Dis. 2005;40:315-8.
11. Chiu CH, Wu TL, Su LH, Chu C, Chia JH, Kuo AJ, et al. The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype choleraesuis. N Engl J Med. 2002; 346:413-9.
12. Sun HY, Tseng SP, Hsueh PR, Hung CC, Hsieh SM, Teng LJ, et al. Occurrence of ceftriaxone resistance in ciprofloxacin-resistant Salmonella enterica serotype Choleraesuis isolates causing recurrent infection. Clin Infect Dis. 2005;40:208-9.
13. Lee CY, Chiu CH, Chuang YY, Su LH, Wu TL, Chang LY, et al. Multidrug-resistant non-typhoid Salmonella infections in a medical center. J Microbiol Immunol Infect. 2002;35: 78-84.
14. Farmer JJ III. Enterobacteriaceae: introduction and identification. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 6th ed. Washington, DC: American Society for Microbiology Press; 1995:438-49.
15. Chiu CH, Wu TL, Su LH, Liu JW, Chu C. Fluoroquinolone resistance in Salmonella enterica serotype Choleraesuis, Taiwan, 2000-2003. Emerg Infect Dis. 2004;10:1674-6.
16. National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial susceptibility testing, 15th informational supplement. NCCLS document M100-S 15. Wayne, PA: National Committee for Clinical Laboratory Standards; 2005.
17. Murray A, Coia JE, Mather H, Brown DJ. Ciprofloxacin resistance in non-typhoidal Salmonella serotypes in Scotland, 1993-2003. J Antimicrob Chemother. 2005;56:110-4.
18. Su LH, Wu TL, Chia JH, Chu C, Kuo AJ, Chiu CH. Increasing ceftriaxone resistance in Salmonella isolates from a university hospital in Taiwan. J Antimicrob Chemother. 2005;55:846-52.
19. Chang CC, Lin YH, Chang CF, Yeh KS, Chiu CH, Chu C, et al. Epidemiologic relationship between fluoroquinolone-resistant Salmonella enterica serovar Choleraesuis strains isolated from humans and pigs in Taiwan (1997 to 2002). J Clin Microbiol. 2005;43:2798-804.
20. Yan JJ, Chiou CS, Lauderdale TL, Tsai SH, Wu JJ. Cephalosporin and ciprofloxacin resistance in Salmonella, Taiwan. Emerg Infect Dis. 2005;11:947-50.
21. Ramos JM, Garcia-Corbeira P, Aguado JM, Arjona R, Ales JM, Soriano F. Clinical significance of primary vs. secondary bacteremia due to nontyphoid Salmonella in patients without AIDS. Clin Infect Dis. 1994;19:777-80.
22. Lee SC, Yang PH, Shieh WB, Lasserre R. Bacteremia due to non-typhi Salmonella: analysis of 64 cases and review. Clin Infect Dis. 1994;19:693-6.
23. Levine WC, Buehler JW, Bean NH, Tauxe RV. Epidemiology of nontyphoidal Salmonella bacteremia during the human immunodeficiency virus epidemic. J Infect Dis. 1991;164: 81-7.
24. Cohen PS, O'Brien TF, Schoenbaum SC, Medeiros AA. The risk of endothelial infection in adults with salmonella bacteremia. Ann Intern Med. 1978;89:931-2.
25. Benenson S, Raveh D, Schlesinger Y, Alberton J, Rudensky B, Hadas-Halpern I, et al. The risk of vascular infection in adult 110:60-3.
26. Chiu CH, Ou JT. Risk factors for endovascular infection due to nontyphoid salmonellae. Clin Infect Dis. 2003;36:835-6.
27. Shimoni Z, Pitlik S, Leibovici L, Samra Z, Konigsberger H, Drucker M, et al. Nontyphoid Salmonella bacteremia: age-related differences in clinical presentation, bacteriology, and outcome. Clin Infect Dis. 1999;28:822-7.
28. Soravia-Dunand VA, Loo VG, Salit IE. Aortitis due to Salmonella: report of 10 cases and comprehensive review of the literature. Clin Infect Dis. 1999;29:862-8.
29. Barrett-Connor E. Bacterial infection and sickle cell anemia. An analysis of 250 infections in 166 patients and a review of the literature. Medicine (Baltimore). 1971;50:97-112.
30. Specht EE. Hemoglobinopathic salmonella osteomyelitis. Orthopedic aspects. Clin Orthop Relat Res. 1971;79:110-8.
31. Chu C, Su LH, Chu CH, Baucheron S, Cloeckaert A, Chiu CH. Resistance to fluoroquinolones linked to gyrA and parC mutations and overexpression of acrAB efflux pump in Salmonella enterica serotype Choleraesuis. Microb Drug Resist. 2005;11:248-53.
32. Chiu CH, Su LH, Chu C. Salmonella enterica serotype Choleraesuis: epidemiology, pathogenesis, clinical disease, and treatment. Clin Microbiol Rev. 2004;17:311-22.
33. Hsueh PR, Teng LJ, Tseng SP, Chang CF, Wan JH, Van JJ, et al. Ciprofloxacin-resistant Salmonella enterica Typhimurium and Choleraesuis from pigs to humans, Taiwan. Emerg Infect Dis. 2004;10:60-8.
34. Miriagou V, Tassios PT, Legakis NJ, Tzouvelekis LS. Expanded-spectrum cephalosporin resistance in non-typhoid Salmonella. Int J Antimicrob Agents. 2004;23:547-55.
35. Parry CM. Antimicrobial drug resistance in Salmonella enterica. Curr Opin Infect Dis. 2003;16:467-72.
36. Chiu CH, Su LH, Chu C, Chia JH, Wu TL, Lin TY, et al. Isolation of Salmonella enterica serotype Choleraesuis resistant to ceftriaxone and ciprofloxacin. Lancet. 2004;363:1285-6.